AstraZeneca Pharma India
| March 25, 2024, 8:37 a.m.
AstraZeneca Pharma India Appoints Vinay Sharma as Business Unit Head for Rare Disease
AstraZeneca Pharma India Ltd. has announced the appointment of Vinay Sharma as the Business Unit Head for Rare Disease, effective July 1, 2024. Sharma, currently serving as the head of Respiratory and Immunology in the Philippines, brings over 23 years of industry experience to his new role. He holds a post-graduate degree in marketing management and business administration and has held various leadership positions in sales, marketing, and patient advocacy across AstraZeneca India and other international markets. Sharma played a pivotal role in launching Forxiga in India.
Read More.Stories
Highlights of India Budget 2024: Finance Minister announces 2 crore more houses under Pradhan Mantri Awas Yojana – Gramin (PMAY-G) . No changes to income tax slabs.
Budget 2024 Key Highlights: Fiscal deficit target for 2024-25 at 5.1% of GDP; no changes to income tax slabs
No Major Tax Changes in Interim Budget, Focus on Growth
Fiscal Deficit Target Lowered to 5.8% in Interim Budget
Infrastructure, Digital Push to Drive Growth in Interim Budget
Education Sector Seeks Higher Allocation, NEP Implementation in Budget
Sitharaman Presents Interim Budget, Focuses on Fiscal Consolidation and Growth
Sitharaman's Last Budget Before 2024 Elections Focuses on Rural India
Latest News